Delpor, Inc. engages in developing and acquiring drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant. Its technologies include Prozor, which is used for the delivery of antipsychotics and other small molecule drugs from a non-mechanical implantable drug delivery device; NANOPOR, a non-mechanical implantable drug delivery device in which sustained release is provided by membrane architecture; and Delos PUMP, a self-contained and electro-osmotically driven implantable drug delivery device to deliver drugs in predetermined patterns. The company was incorporated in 2009 and is based in San Francisco, California.
Funding Rounds (2) - $1.37MUpdate
Current Team (1)Update
|Jan 3, 2014||SEC - SEC FORM D|
|Oct 4, 2013||SEC - SEC FORM D|
|Jun 29, 2010||Xconomy - The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More|
409 Illinois St.
San Francisco, California 94158